BRPI0414732A - piridilacetilenos para uso como radiotraçadores e agentes de imageamento - Google Patents

piridilacetilenos para uso como radiotraçadores e agentes de imageamento

Info

Publication number
BRPI0414732A
BRPI0414732A BRPI0414732-4A BRPI0414732A BRPI0414732A BR PI0414732 A BRPI0414732 A BR PI0414732A BR PI0414732 A BRPI0414732 A BR PI0414732A BR PI0414732 A BRPI0414732 A BR PI0414732A
Authority
BR
Brazil
Prior art keywords
pyridylacetylenes
radiotracers
imaging agents
pyridylacetylene
radiators
Prior art date
Application number
BRPI0414732-4A
Other languages
English (en)
Inventor
Fabrizio Gasparini
Yves Auberson
Lea Kessler
Simon Mensah Ametamey
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0414732A publication Critical patent/BRPI0414732A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"PIRIDILACETILENOS PARA USO COMO RADIOTRAçADORES E AGENTES DE IMAGEAMENTO". A presente invenção refere-se a novos derivados de piridilacetilenos, sua preparação, seu uso como radiotraçadores/marcadores e composições contendo-os.
BRPI0414732-4A 2003-09-26 2004-09-24 piridilacetilenos para uso como radiotraçadores e agentes de imageamento BRPI0414732A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0322612.3A GB0322612D0 (en) 2003-09-26 2003-09-26 Organic compounds
PCT/EP2004/010743 WO2005030723A1 (en) 2003-09-26 2004-09-24 Pyridylacetylenes for use as radiotracers and imaging agents

Publications (1)

Publication Number Publication Date
BRPI0414732A true BRPI0414732A (pt) 2006-11-21

Family

ID=29286926

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414732-4A BRPI0414732A (pt) 2003-09-26 2004-09-24 piridilacetilenos para uso como radiotraçadores e agentes de imageamento

Country Status (13)

Country Link
US (2) US8674110B2 (pt)
EP (1) EP1670762B1 (pt)
JP (1) JP4965255B2 (pt)
CN (1) CN100430380C (pt)
AU (2) AU2004275971B2 (pt)
BR (1) BRPI0414732A (pt)
CA (1) CA2539469C (pt)
ES (1) ES2400713T3 (pt)
GB (1) GB0322612D0 (pt)
MX (1) MXPA06003424A (pt)
PL (1) PL1670762T3 (pt)
PT (1) PT1670762E (pt)
WO (1) WO2005030723A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
CN102762572A (zh) 2010-02-01 2012-10-31 诺瓦提斯公司 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
EP2531490B1 (en) 2010-02-02 2014-10-15 Novartis AG Cyclohexyl amide derivatives as crf receptor antagonists
WO2012004400A1 (en) 2010-07-09 2012-01-12 Recordati Ireland Limited Novel spiroheterocyclic compounds as mglu5 antagonists
UY34094A (es) 2011-05-27 2013-01-03 Novartis Ag Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
WO2013164790A1 (en) 2012-05-03 2013-11-07 Novartis Ag L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6843979B2 (en) * 1999-04-26 2005-01-18 Emory University 4-haloethenylphenyl tropane:serotonin transporter imaging agents
AU767726B2 (en) * 1999-04-30 2003-11-20 Pfizer Products Inc. Radiotracers for in vivo study of acetylcholinesterase and Alzheimer's disease
WO2001001621A2 (en) * 1999-06-30 2001-01-04 Sun Microsystems, Inc. Customizing web content based on network conditions
JP4815083B2 (ja) 1999-08-31 2011-11-16 メルク・シャープ・エンド・ドーム・コーポレイション 複素環化合物およびそれの使用方法
GB0103045D0 (en) * 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
JP4070431B2 (ja) * 2001-07-10 2008-04-02 ジーイー・ヘルスケア・リミテッド モノアミン再取込み部位のマッピング用ヨウ素付加神経プローブ
JP2006513996A (ja) 2002-10-24 2006-04-27 メルク　エンド　カムパニー　インコーポレーテッド 代謝調節型グルタミン酸受容体結合用トレーサーとしてのアルキン誘導体

Also Published As

Publication number Publication date
CN100430380C (zh) 2008-11-05
US8674110B2 (en) 2014-03-18
JP2007506698A (ja) 2007-03-22
CN1856468A (zh) 2006-11-01
PL1670762T3 (pl) 2013-05-31
AU2008261192B2 (en) 2011-08-04
AU2008261192A1 (en) 2009-01-22
PT1670762E (pt) 2013-02-07
EP1670762B1 (en) 2012-12-05
ES2400713T3 (es) 2013-04-11
MXPA06003424A (es) 2006-06-20
AU2004275971B2 (en) 2008-10-02
AU2004275971A1 (en) 2005-04-07
EP1670762A1 (en) 2006-06-21
WO2005030723A1 (en) 2005-04-07
JP4965255B2 (ja) 2012-07-04
US20090010838A1 (en) 2009-01-08
CA2539469C (en) 2012-06-19
GB0322612D0 (en) 2003-10-29
CA2539469A1 (en) 2005-04-07
US20140142318A1 (en) 2014-05-22

Similar Documents

Publication Publication Date Title
PA8595901A1 (es) "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos
CR9786A (es) Compuestos de bencimidazol-tiofeno
AR028948A1 (es) Compuestos novedosos
UY26495A1 (es) " derivados de tiazolilamida"
BRPI0408347B8 (pt) derivados de pirimidina, seu uso, e composição e combinação farmacêuticas
IL181529A0 (en) Diagnostic compounds
AR030185A1 (es) Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas
SV2001000004A (es) Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa
SE0201544D0 (sv) Novel compounds and thier use
SV2002000776A (es) Nuevas imidazotriazinonas sustituidas ref.lea 34 985-sv
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
MXPA05009682A (es) Metodos de radiofluorinacion de vectores biologicamente activos.
BR0311189A (pt) Composições farmacêuticas contendo polimorfo a de flibanserin
ES2187261B2 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
UY27424A1 (es) Agentes antidiabéticos
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
DOP2006000268A (es) Agentes antibacterianos
PA8582201A1 (es) Indoles 2,7-sustituidos
CL2004000804A1 (es) Procedimiento de preparacion en una sola etapa de n-(n'-glicilo substituida)-2-cianopirrolidina.
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
BR0212353A (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0417950A (pt) composições farmacêuticas
HN2001000235A (es) Derivados puentes de piperazina
ECSP034813A (es) Arilsulfonamidas como agentes antivirales
AR027575A1 (es) Benzoilciclohexenonas substituidas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 11A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2325 DE 28-07-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.